This is similar to the negative relationship seen in patients with chronic kidney disease, where decreased kidney CPT1A mRNA expression was linked with increased accumulation of short and middle chain acylcarnitines (Miguel et al., 2021). Here, CPT1A is linked to chronic kidney disease.